Alcohol & Men's Sexual Risk Behaviors
Conditions: Sexual Behavior; Alcohol Drinking; Sexual Aggression; Emotions Interventions: Behavioral: Alcoholic Beverage; Behavioral: Non-alcoholic Beverage; Behavioral: Partner Negative Mood Manipulation; Behavioral: Partner Positive Mood Manipulation Sponsors: Arizona State University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients
Conditions: Severe Acute Alcoholic Hepatitis; Alcohol; Intestinal Microbiota; Corticosteroids Interventions: Other: stool withdrawal Sponsors: Centre Hospitalier Universitaire, Amiens; CH Montdidier Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis
Conditions: Severe Alcoholic Hepatitis Interventions: Drug: Prednisolone; Other: Standard Medical therapy; Drug: Placebo Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: GODEX; Drug: Placebo Sponsors: Yoon Jun Kim; Celltrion Pharm, Inc. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials
A Trial to Learn How Safe AZD9550 is in People With Type 2 Diabetes Who Are Overweight or Obese
Conditions: Non-alcoholic Steatohepatitis (NASH) Interventions: Drug: AZD9550; Drug: Placebo Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis
Conditions: Liver Diseases Interventions: Other: Liver Fine-Needle Aspiration Sponsors: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
A Phase 1 Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine
Conditions: Alcohol Use Disorder Interventions: Drug: Prazosin + cyproheptadine; Drug: KT110 Sponsors: Kinnov Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine
Conditions: Alcohol Use Disorder Interventions: Drug: Prazosin + cyproheptadine; Drug: KT110 Sponsors: Kinnov Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome Interventions: Other: Dietary macronutrient composition Sponsors: Hvidovre University Hospital; University of Copenhagen; Danish Research Centre for Magnetic Resonance Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The Effects of Sex Hormones and Alcohol on Sleep
Conditions: Alcohol Use Disorder Interventions: Drug: Ethanol; Drug: Saline Sponsors: Lauren Whitehurst; Ohio State University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Benefits of Trimetazidine in MAFLD Pateints
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: conventional treatment; Drug: Furosemide or other alternatives , Niaspan or other alternatives; Drug: Trimetazidine Sponsors: October 6 University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
Conditions: Alcohol Use Disorder; Human Immunodeficiency Virus Interventions: Dietary Supplement: 10 day prebiotic consumption Sponsors: Rush University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
Conditions: Obesity; Liver Diseases; Liver Fibrosis; Liver Fat; NAFLD; Weight Loss; Insulin Resistance; Insulin Sensitivity; Insulin Sensitivity/Resistance; Metabolic Diseases; Diabetes; Diabetes Mellitus, Type 2; Diabetes Mellitus; NASH With Fibrosis; Non-Alcoholic Fatty Liver Disease; Non Alcoholic Fatty Liver; Non-alcoholic Steatohepatitis Interventions: Device: ESG; Drug: GLP1-RA Sponsors: Pichamol Jirapinyo, MD, MPH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria
Conditions: Hyperoxaluria; Nonalcoholic Fatty Liver Disease; Kidney Stone Interventions: Drug: BMN 255; Drug: Placebo Sponsors: BioMarin Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
Conditions: Alcohol Consumption; Heavy Drinker; Alcohol Use Disorder (AUD) Interventions: Drug: Mavoglurant; Other: Placebo Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
